Patents-Review.com
🔗 Permalink
Assignee profile:

SMALL PHARMA LTD

City:

London

Country:

United Kingdom

Published Applications:

21

Last publication date:

2023-08-10

Patent Grants:

15

Last grant date:

2024-09-10

Top Inventors for applications by SMALL PHARMA LTD

These are the the leading inventors for applications assigned to SMALL PHARMA LTD:

Recent patent applications by SMALL PHARMA LTD

SMALL PHARMA LTD based in London, GB has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2023-08-10 ✅ Patent 12,084,417 granted on 2024-09-10
US20230250059A1
Chemistry; metallurgy

Synthesis of N,N-dimethyltryptamine-type compounds, methods, and uses

 #2 | 2023-06-15 ✅ Patent 12,251,371 granted on 2025-03-18
US20230181530A1
Human necessities

Deuterated or partially deuterated N,N-dimethyltryptamine compounds

 #3 | 2023-06-01 ✅ Patent 12,157,723 granted on 2024-12-03
US20230167056A1
Chemistry; metallurgy

Compounds

 #4 | 2023-03-23 ✅ Patent 11,697,638 granted on 2023-07-11
US20230086574A1
Chemistry; metallurgy

5-methoxy-N,N-dimethyltryptamine crystalline forms

 #5 | 2022-10-06 ✅ Patent 12,343,327 granted on 2025-07-01
US20220313660A1
Human necessities

INJECTABLE FORMULATIONS

 #6 | 2022-09-29
US20220306569A1
Chemistry; metallurgy

CRYSTALLINE FORMS OF HYDROXYNORKETAMINE

 #7 | 2022-09-08 ✅ Patent 11,578,039 granted on 2023-02-14
US20220281818A1
Chemistry; metallurgy

Compounds

 #8 | 2022-06-30 ✅ Patent 11,660,289 granted on 2023-05-30
US20220202775A1
Human necessities

Deuterated or partially deuterated N,N-dimethyltryptamine compounds

 #9 | 2022-06-02
US20220169606A1
Chemistry; metallurgy

COMPOSITIONS AND COMPOUNDS FOR BIOANALYSIS

 #10 | 2022-06-02 ✅ Patent 12,076,311 granted on 2024-09-03
US20220168275A1
Human necessities

Therapeutic compositions comprising deuterated or partially deuterated N,N-dimethyltryptamine compounds

 #11 | 2022-06-02
US20220168274A1
Human necessities

Parenteral Formulation

 #12 | 2022-03-17 ✅ Patent 11,773,062 granted on 2023-10-03
US20220081396A1
Chemistry; metallurgy

Deuterated compounds

 #13 | 2022-03-03 ✅ Patent 11,406,619 granted on 2022-08-09
US20220062238A1
Human necessities

Injectable formulations

 #14 | 2022-03-03
US20220062237A1
Human necessities

INJECTABLE FORMULATION

 #15 | 2021-12-30 ✅ Patent 11,471,417 granted on 2022-10-18
US20210403426A1
Chemistry; metallurgy

Deuterated N,N-dimethyltryptamine compounds

 #16 | 2021-12-23 ✅ Patent 11,643,390 granted on 2023-05-09
US20210395201A1
Chemistry; metallurgy

Synthesis of N,N-dimethyltryptamine-type compounds, methods, and uses

 #17 | 2021-12-09 ✅ Patent 12,042,564 granted on 2024-07-23
US20210378969A1
Human necessities

Therapeutic solid dosage forms

 #18 | 2021-10-14
US20210315840A1
Human necessities

SOLID ORAL DOSAGE FORMS OF KETAMINE DERIVATIVES

 #19 | 2020-12-17 ✅ Patent 11,771,681 granted on 2023-10-03
US20200390746A1
Human necessities

Therapeutic compounds

 #20 | 2020-05-21 ✅ Patent 11,377,416 granted on 2022-07-05
US20200157040A1
Chemistry; metallurgy

Crystalline forms of hydroxynorketamine

 #21 | 2019-12-19
US20190380978A1
Human necessities

SOLID ORAL DOSAGE FORMS OF 2R,6R-HYDROXYNORKETAMINE OR DERIVATIVES THEREOF

Also check out SMALL PHARMA LTD's (London, United Kingdom) applicant profile with 9 patent applications submitted.

AssigneeID:

158483 ⎘